ARJO B Stock Overview
Develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 4/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Arjo AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 34.60 |
52 Week High | SEK 53.75 |
52 Week Low | SEK 32.76 |
Beta | 0.41 |
1 Month Change | 2.00% |
3 Month Change | -20.75% |
1 Year Change | -12.93% |
3 Year Change | -67.39% |
5 Year Change | -23.89% |
Change since IPO | 40.48% |
Recent News & Updates
Recent updates
Arjo AB (publ) Just Missed EPS By 32%: Here's What Analysts Think Will Happen Next
Oct 21Market Participants Recognise Arjo AB (publ)'s (STO:ARJO B) Earnings
Sep 10Returns Are Gaining Momentum At Arjo (STO:ARJO B)
Aug 06Arjo AB (publ) (STO:ARJO B) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Jul 16Arjo (STO:ARJO B) Will Pay A Larger Dividend Than Last Year At SEK0.90
Apr 16We Think Shareholders May Want To Consider A Review Of Arjo AB (publ)'s (STO:ARJO B) CEO Compensation Package
Apr 12Arjo (STO:ARJO B) Is Increasing Its Dividend To SEK0.90
Mar 30Arjo (STO:ARJO B) Is Increasing Its Dividend To SEK0.90
Mar 16Arjo's (STO:ARJO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 02Arjo (STO:ARJO B) Is Increasing Its Dividend To SEK0.90
Feb 17Investors Appear Satisfied With Arjo AB (publ)'s (STO:ARJO B) Prospects As Shares Rocket 25%
Feb 06Arjo's (STO:ARJO B) Dividend Will Be Increased To SEK0.90
Feb 03Results: Arjo AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 01Arjo (STO:ARJO B) Seems To Use Debt Quite Sensibly
Oct 09Arjo (STO:ARJO B) Is Doing The Right Things To Multiply Its Share Price
Sep 18Are Investors Undervaluing Arjo AB (publ) (STO:ARJO B) By 44%?
May 30There's Been No Shortage Of Growth Recently For Arjo's (STO:ARJO B) Returns On Capital
May 17Here's Why Arjo (STO:ARJO B) Can Manage Its Debt Responsibly
Apr 21Arjo (STO:ARJO B) Will Pay A Smaller Dividend Than Last Year
Apr 05Arjo's (STO:ARJO B) Dividend Is Being Reduced To SEK0.85
Feb 25Arjo's (STO:ARJO B) Dividend Is Being Reduced To SEK0.85
Feb 11Arjo (STO:ARJO B) Will Pay A Smaller Dividend Than Last Year
Jan 28Is There An Opportunity With Arjo AB (publ)'s (STO:ARJO B) 48% Undervaluation?
Jan 17Be Wary Of Arjo (STO:ARJO B) And Its Returns On Capital
Dec 16Here's Why Arjo (STO:ARJO B) Can Manage Its Debt Responsibly
Oct 27Be Wary Of Arjo (STO:ARJO B) And Its Returns On Capital
Aug 24These 4 Measures Indicate That Arjo (STO:ARJO B) Is Using Debt Reasonably Well
May 25Arjo (STO:ARJO B) Has Some Way To Go To Become A Multi-Bagger
May 13Shareholder Returns
ARJO B | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 0.3% | 0.9% | -1.6% |
1Y | -12.9% | -6.6% | 6.5% |
Return vs Industry: ARJO B underperformed the Swedish Medical Equipment industry which returned -8.8% over the past year.
Return vs Market: ARJO B underperformed the Swedish Market which returned 6.1% over the past year.
Price Volatility
ARJO B volatility | |
---|---|
ARJO B Average Weekly Movement | 5.4% |
Medical Equipment Industry Average Movement | 7.2% |
Market Average Movement | 5.6% |
10% most volatile stocks in SE Market | 11.4% |
10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: ARJO B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: ARJO B's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1957 | 6,500 | Joacim Lindoff | www.arjo.com/int/ |
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions.
Arjo AB (publ) Fundamentals Summary
ARJO B fundamental statistics | |
---|---|
Market cap | SEK 9.42b |
Earnings (TTM) | SEK 505.00m |
Revenue (TTM) | SEK 11.18b |
18.7x
P/E Ratio0.8x
P/S RatioIs ARJO B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ARJO B income statement (TTM) | |
---|---|
Revenue | SEK 11.18b |
Cost of Revenue | SEK 6.31b |
Gross Profit | SEK 4.87b |
Other Expenses | SEK 4.37b |
Earnings | SEK 505.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
Earnings per share (EPS) | 1.85 |
Gross Margin | 43.59% |
Net Profit Margin | 4.52% |
Debt/Equity Ratio | 53.3% |
How did ARJO B perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield49%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 06:52 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Arjo AB (publ) is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sten Gustafsson | ABG Sundal Collier |
Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
Karl Norén | Danske Bank |